Susquehanna International Group’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.68M | Sell |
38,697
-31,641
| -45% | -$1.37M | ﹤0.01% | 2504 |
|
2025
Q1 | $2.63M | Buy |
70,338
+39,050
| +125% | +$1.46M | ﹤0.01% | 1932 |
|
2024
Q4 | $1.42M | Sell |
31,288
-20,242
| -39% | -$917K | ﹤0.01% | 2457 |
|
2024
Q3 | $3.03M | Buy |
51,530
+36,407
| +241% | +$2.14M | ﹤0.01% | 1492 |
|
2024
Q2 | $595K | Sell |
15,123
-1,535
| -9% | -$60.4K | ﹤0.01% | 3268 |
|
2024
Q1 | $1.11M | Buy |
16,658
+7,177
| +76% | +$477K | ﹤0.01% | 2502 |
|
2023
Q4 | $265K | Buy |
+9,481
| New | +$265K | ﹤0.01% | 4669 |
|